BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28988279)

  • 1. Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.
    Belkhelfa-Slimani R; Djerdjouri B
    Inflammopharmacology; 2018 Apr; 26(2):621-634. PubMed ID: 28988279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
    Tafaghodi M; Eskandari M; Khamesipour A; Jaafari MR
    Exp Parasitol; 2011 Oct; 129(2):107-14. PubMed ID: 21767536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.
    Soudi S; Hosseini AZ; Hashemi SM
    Parasite Immunol; 2011 Oct; 33(10):561-71. PubMed ID: 21781137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY; Fathy FM; Hegazy EH; Hussein ED; Eissa MM; Said DE
    J Egypt Soc Parasitol; 2006 Apr; 36(1):159-76, following 76. PubMed ID: 16605109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production.
    Li J; Hunter CA; Farrell JP
    J Immunol; 1999 Jan; 162(2):974-9. PubMed ID: 9916722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylcholine exacerbates Leishmania major-dendritic cell infection through interleukin-10 and a burst in arginase1 and indoleamine 2,3-dioxygenase activities.
    Tounsi N; Meghari S; Moser M; Djerdjouri B
    Int Immunopharmacol; 2015 Mar; 25(1):1-9. PubMed ID: 25601495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.
    Stenger S; Thüring H; Röllinghoff M; Bogdan C
    J Exp Med; 1994 Sep; 180(3):783-93. PubMed ID: 7520472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice.
    Montakhab-Yeganeh H; Shafiei R; Najm M; Masoori L; Aspatwar A; Badirzadeh A
    PLoS One; 2022; 17(2):e0263993. PubMed ID: 35167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4-deficient Balb/c mice resist infection with Leishmania major.
    Kopf M; Brombacher F; Köhler G; Kienzle G; Widmann KH; Lefrang K; Humborg C; Ledermann B; Solbach W
    J Exp Med; 1996 Sep; 184(3):1127-36. PubMed ID: 9064329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
    Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
    Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of scid mice to establishment of Leishmania major infection.
    Guy RA; Belosevic M
    Clin Exp Immunol; 1995 Jun; 100(3):440-5. PubMed ID: 7774053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice.
    Iborra S; Parody N; Abánades DR; Bonay P; Prates D; Novais FO; Barral-Netto M; Alonso C; Soto M
    Microbes Infect; 2008; 10(10-11):1133-41. PubMed ID: 18603012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
    Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.